机译:患者的B3GALT6 B3GALT6变体最初被描述为Al-Gazali综合征,并在一些β3GALT6-病态突变机制中暗示内质网状质量控制
Department of Pathology College of Medicine and Heath SciencesUnited Arab Emirates UniversityAl;
Department of Pathology College of Medicine and Heath SciencesUnited Arab Emirates UniversityAl;
College of pharmacyAl Ain University of Science and TechnologyAl Ain United Arab Emirates;
Department of Pathology College of Medicine and Heath SciencesUnited Arab Emirates UniversityAl;
Department of Pathology College of Medicine and Heath SciencesUnited Arab Emirates UniversityAl;
Department of Paediatrics College of Medicine and Heath SciencesUnited Arab Emirates UniversityAl;
Al‐Gazali syndrome; β3GalT6‐pathy; B3GALT6 variant; defective GAGs synthesis; ER quality control;
机译:患者的B3GALT6 B3GALT6变体最初被描述为Al-Gazali综合征,并在一些β3GALT6-病态突变机制中暗示内质网状质量控制
机译:由于B3GALT6突变引起的糖胺聚糖合成的缺陷启动会导致多效性埃勒斯-丹洛斯综合征等结缔组织疾病
机译:通过抑制内质网质量控制来拯救肌聚糖突变与最小的结构修饰有关
机译:酿酒酵母内质网质量控制体系的作用机理研究。
机译:由于B3GALT6突变引起的糖胺聚糖合成的缺陷起始导致多发性埃勒斯-丹洛斯综合征等结缔组织疾病
机译:由于B3GALT6突变引起的糖胺聚糖合成的缺陷起始导致多发性埃勒斯-丹洛斯综合征等结缔组织疾病